PTC Therapeutics, Inc. (PTCT) Social Stream
Ptc Therapeutics Inc (PTCT) Price Targets From Analysts
Use the tables below to see what analysts covering Ptc Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 12 | $90 | $45 | $61.58 | $40.59 | 51.71% |
The Trend in the Analyst Price Target
PTCT's average price target has moved up $1.38 over the prior 75 days.
Over the past 178 days, PTCT's average upside potential has been 8%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-11-25 | 12 | 90 | 45 | 61.58 | 63.53 | -3.07% |
| 2020-11-23 | 12 | 90 | 45 | 61.58 | 62.24 | -1.06% |
| 2020-11-19 | 12 | 90 | 45 | 61.58 | 62.83 | -1.99% |
| 2020-10-30 | 12 | 90 | 45 | 61.25 | 52.19 | 17.36% |
| 2020-09-30 | 10 | 86 | 45 | 60.20 | 46.75 | 28.77% |
| 2020-09-11 | 10 | 86 | 45 | 60.20 | NA | NA% |
| 2020-08-21 | 10 | 86 | 46 | 60.30 | NA | NA% |
| 2020-08-10 | 9 | 86 | 46 | 60.00 | NA | NA% |
| 2020-08-07 | 9 | 86 | 46 | 61.44 | NA | NA% |
| 2020-07-17 | 9 | 86 | 50 | 62.22 | NA | NA% |
| 2020-07-15 | 9 | 85 | 50 | 62.00 | NA | NA% |
| 2020-07-02 | 9 | 85 | 50 | 61.22 | NA | NA% |
| 2020-06-22 | 9 | 85 | 45 | 60.44 | NA | NA% |
| 2020-06-20 | 9 | 85 | 45 | 60.44 | NA | NA% |
| 2020-05-31 | 9 | 85 | 45 | 60.44 | NA | NA% |
PTCT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.62 | 3 | 4 | 6 | 0 | 0 | 13 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PTCT as an investment opportunity.
- Ptc Therapeutics Inc's variance in analysts' estimates is less than 11.48% of all US stocks.
- PTCT has a greater number of analysts covering the stock than 90.74% of Pharmaceutical Products stocks.
- Ptc Therapeutics Inc's average analyst price target is greater than 84.43% of Pharmaceutical Products stocks.
- Ptc Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 83.4% of stocks in the mid market cap category.
Stocks similar to Ptc Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NKTR, BHC and FOLD.
Is PTCT a Buy, Hold or Sell? See the POWR Ratings now!